To Enrich Its Existing Mental Residence Portfolio, the Corporation Submitted an Additional U.S. Provisional Patent Application Directed to: Different Pharmaceutical Cannabinoid Shipping Methods
NEW YORK, NY, March 22, 2021 (World NEWSWIRE) — by means of NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a income producing, diversified lifestyle sciences enterprise, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant), further item choices, as effectively as an ongoing Pharmaceutical Advancement initiative, currently declared that on March 17, 2021, the Firm transformed its U.S. Provisional Patent Software (filed on March 17, 2020) to a U.S. Non-Provisional Patent Software. This Non-Provisional Patent Application relates to the Company’s proposed Pharmaceutical Cannabinoid Chewing Gum Shipping and delivery Program – currently being designed to address: Nausea Derived from Energetic Chemotherapy Treatment.
Also on March 17, 2021, to enhance its present intellectual residence (“IP”) portfolio, the Enterprise submitted an more U.S. Provisional Patent Software directed to: Substitute Pharmaceutical Cannabinoid Shipping Units.
The Enterprise continues to comprehend important and substance progress with regard to its ongoing Pharmaceutical development endeavours. The Corporation expects to deliver extra update(s) to shareholders (relating to clinical trials), within the near expression.
ABOUT TAURIGA SCIENCES, INC.
Tauriga Sciences, Inc. (TAUG) is a profits generating, diversified existence sciences business, engaged in several big organization routines and initiatives. The business manufactures and distributes many proprietary retail goods and item traces, generally focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market phase. The key product or service line, branded as Tauri-Gum™, is made up of a proprietary nutritional supplement chewing gum that is Kosher accredited, Halal accredited, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Flavor: Pear Bellini). The Company’s commercialization method consists of a wide array of retail shoppers, distributors, and a quickly-growing E-Commerce organization section (E-Commerce site: www.taurigum.com). You should go to our company web page, for further info, as well as inquiries, at http://www.tauriga.com
Complementary to the Company’s retail business, is its ongoing Pharmaceutical Growth initiative. This relates to the improvement of a proposed Pharmaceutical quality variation of Tauri-Gum™, for nausea regulation (particularly created for the next indicator: Patients Subjected to Ongoing Chemotherapy Procedure). On March 18, 2020, the Company introduced that it experienced filed a provisional U.S. patent software covering its pharmaceutical grade edition of Tauri-Gum™. The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, Procedures OF Producing, AND Methods OF TREATMENT”. On December 18, 2020 the Corporation disclosed that it experienced entered into a Master Services Agreement with CSTI to guide the Company’s clinical progress endeavours.
The Company is headquartered in Wappingers Falls, New York. In addition, the Firm operates two comprehensive time E-Commerce fulfillment facilities: just one found in Montgomery, Texas and the other in Brooklyn, New York.
DISCLAIMER — Forward-Seeking Statements
This push launch incorporates specific “forward-searching statements” as defined by the Non-public Securities Litigation Reform Act of 1995 which characterize management’s beliefs and assumptions regarding foreseeable future activities. These forward-on the lookout statements are normally indicated by employing phrases such as “may,” “will,” “expects,” “anticipates,” thinks, “hopes,” “believes,” or programs, and may possibly involve statements pertaining to company targets as effectively as the attainment of sure company targets and milestones. Forward-looking statements are based mostly on existing circumstances and on management’s present beliefs with respect to events that have not occurred, that may perhaps not take place, or that may perhaps arise with diverse repercussions or timing than individuals now assumed or anticipated. Genuine benefits may possibly vary materially from individuals expressed in forward-looking statements because of to recognised and unfamiliar dangers and uncertainties, this kind of as are not ensures of basic financial and business enterprise situations, the capability to correctly produce and market items, consumer and enterprise intake practices, the ability to consummate prosperous acquisition and licensing transactions, fluctuations in trade premiums, and other variables above which Tauriga has little or no command. Numerous of these hazards and uncertainties are talked about in better depth in the “Risk Factors” area of Tauriga’s Sort 10-K and other periodic filings built from time to time with the Securities and Trade Commission. These forward-hunting statements are made only as of the day of this launch, and Tauriga assumes no obligation to update forward-hunting statements to replicate subsequent situations or circumstances. You should really not area undue reliance on these forward-wanting statements.
Tauriga Sciences, Inc.
4 Nancy Court docket, Suite 4
Wappingers Falls, NY 12590
Main Govt Officer
Mr. Seth M. Shaw
Email: [email protected]
Mobile # (917) 796 9926
Company Instagram: @taurigum
Personalized Instagram: @sethsms47
Corp. Web-site: www.tauriga.com
E-Commerce Website: www.taurigum.com